Kaundinya Ganesh Venkataraman 4/A
4/A · MOMENTA PHARMACEUTICALS INC · Filed Mar 27, 2018
Insider Transaction Report
Form 4/AAmended
Venkataraman Ganesh
Senior V.P., Research
Transactions
- Award
Restricted Stock Units
2018-02-12+50,000→ 50,000 total→ Common Stock (50,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-02-12$7.41/sh−10,103$74,863→ 0 totalExercise: $7.41From: 2012-02-22Exp: 2018-02-22→ Common Stock (10,103 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- [F2]The original Form 4 filed on February 14, 2018 is amended by this Form 4/A to correctly reflect the reporting person's acquisition of 50,000 restricted stock units as an acquisition in Column 5.
- [F3]Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.
- [F4]The original Form 4 filed on February 14, 2018 is amended by this Form 4/A to correctly reflect the reporting person's exercise of 10,103 stock options as a disposition in Column 5.